Journal of Vascular Surgery
Volume 52, Issue 2 , Pages 356-361 , August 2010

Below knee bare nitinol stent placement in high-risk patients with critical limb ischemia is still durable after 24 months of follow-up

  • Konstantinos P. Donas, MD, PhD

      Affiliations

    • Department of Vascular Surgery, St. Franziskus Hospital, Münster, Germany
    • Center of Vascular and Endovascular Surgery, Münster University Hospital, Münster, Germany
    • Corresponding Author InformationCorrespondence: Dr. Konstantinos P. Donas, MD, PhD, Department of Vascular Surgery, St. Franziskus Hospital and Center of Vascular and Endovascular Surgery, Münster University Hospital, Hohenzollernring 72, 48145 Münster, Germany
  • ,
  • Giovanni Torsello, MD, PhD

      Affiliations

    • Department of Vascular Surgery, St. Franziskus Hospital, Münster, Germany
    • Center of Vascular and Endovascular Surgery, Münster University Hospital, Münster, Germany
  • ,
  • Arne Schwindt, MD

      Affiliations

    • Department of Vascular Surgery, St. Franziskus Hospital, Münster, Germany
    • Center of Vascular and Endovascular Surgery, Münster University Hospital, Münster, Germany
  • ,
  • Eva Schönefeld, MD, PhD

      Affiliations

    • Department of Vascular Surgery, St. Franziskus Hospital, Münster, Germany
    • Center of Vascular and Endovascular Surgery, Münster University Hospital, Münster, Germany
  • ,
  • Olga Boldt

      Affiliations

    • Department of Vascular Surgery, St. Franziskus Hospital, Münster, Germany
    • Center of Vascular and Endovascular Surgery, Münster University Hospital, Münster, Germany
  • ,
  • Georgios A. Pitoulias, MD, PhD

      Affiliations

    • Center of Vascular and Endovascular Surgery, Münster University Hospital, Münster, Germany

Received 2 November 2009 ,Accepted 24 February 2010.

References 

  1. BASIL Investigators. Bypass versus angioplasty in severe ischemia of the leg vices (BASIL): multicentre, randomised controlled trial. Lancet. 2005;366:1925–1934
  2. Feiring AJ, Wesolowski AA, Lade S. Primary stent-supported angioplasty for treatment of below-knee critical limb ischemia and severe claudication. J Am Coll Cardiol. 2004;44:2307–2314
  3. Rand T, Basile A, Cejna M, et al. PTA versus carbofilm-coated stents in infrapopliteal arteries: pilot study. Cardiovasc Intervent Radiol. 2006;29:29–38
  4. Bosiers M, Deloose K, Verbist J, Peeters P. Percutaneous transluminal angioplasty for treatment of “below-the-knee” critical limb ischemia: early outcomes following the use of sirolimus-eluting stents. J Cardiovasc Surg. 2006;47:171–176
  5. Peregrin JH, Smirova S, Koznar B, Novotny J, Kovac J, Lastovickova J, et al. Self-expandable stent placement in infrapopliteal arteries after unsuccessful angioplasty failure: one-year follow-up. Cardiovasc Intervent Radiol. 2008;31:860–864
  6. Bosiers M, Deloose K, Verbist J, Peeters P. First clinical application of absorbable metal stents in the treatment of critical limb ischemia: 12-month results. Vasc Dis Manage. 2005;2:86–91
  7. Bosiers M, Deloose K, Verbist J, Peeters P. Nitinol stenting for treatment of “below-the-knee'' critical limb ischemia: 1-year angiographic outcome after Xpert stent implantation. J Cardiovasc Surg. 2007;48:455–461
  8. TransAntlantic Inter-Society Consensus (TASC) on management of peripheral arterial disease (PAD). J Vasc Surg. 2000;31:1–296
  9. Kickuth R, Hak Keo H, Triller J, Ludwig K, Do DD. Initial clinical experience with the 4-F self-expanding Xpert stent system for infrapopliteal treatment of patients with severe claudication and critical limb ischemia. J Vasc Interv Radiol. 2007;18:703–708
  10. Siablis D, Kraniotis P, Karnabatidis . Sirolimus-eluting versus bare stents for bailout after suboptimal infrapopliteal angioplasty for critical limb ischemia: 6-month angiographic results from a nonrandomized prospective single-center study. J Endovasc Ther. 2005;12:685–695
  11. Donas K, Schwindt A, Schönefeld T, Tessarek J, Torsello G. Below knee bare nitinol stent placement for high-risk patients with critical limb ischemia and unlimited supragenicular inflow as treatment of choice. Eur J Vasc Endovasc Surg. 2009;37:688–693
  12. Duda SH, Pusich B, Richter G. Sirolimus-eluting stents for the treatment of obstructive superficial artery disease: six-month results. Circulation. 2002;106:1505–1509
  13. Sabeti S, Schillinger M, Amighi J, Sherif C, Mlekusch W, Ahmadi R, et al. Primary patency of femoropopliteal arteries treated with nitinol versus stainless steel self-expanding stents: propensity score-adjusted analysis. Radiology. 2004;232:516–521
  14. Schillinger M, Sabeti S, Dick P, Amighi J, Mlekusch W, Schlager O, et al. Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Circulation. 2007;29:2745–2749115
  15. Biondi-Zoccai GL, Sangiorgi G, Lotrionte M, Feiring A, Commeau P, Fusaro M, et al. Infragenicular stent implantation for below-the-knee atherosclerotic disease: clinical evidence from an international collaborative meta-analysis on 640 patients. J Endovasc Ther. 2009;16:251–260
  16. Karnabatidis D, Katsanos K, Siablis D. Infrapopliteal stents: overview and unresolved issues. J Endovasc Ther. 2009;16:153–162
  17. Schwarzmaier-D′Assie , Karnik R, Bonner G, Vavrik J, Slany J. Fracture of a drug-eluting stent in the tibioperoneal trunk following bifurcation stenting. J Endovasc Ther. 2007;14:106–109
  18. Karnabatidis D, Katsanos K, Spiliopoulos S, Diamantopoulos A, Kagadis GC, Siablis D. Incidence, anatomical location, and clinical significance of compressions and fractures in infrapopliteal balloon expandable metal stent. J Endovasc Ther. 2009;16:15–22

 Competition of interest: none.

 The editors and reviewers of this article have no relevant financial relationships to disclose per the JVS policy that requires reviewers to decline review of any manuscript for which they may have a competition of interest.

PII: S0741-5214(10)00666-X

doi: 10.1016/j.jvs.2010.02.281

Journal of Vascular Surgery
Volume 52, Issue 2 , Pages 356-361 , August 2010